FTC fines bogus melanoma diagnosing apps

MelApp.htm

The FTC has fined two developers who made bogus skin cancer detection apps.

According to the FTC's complaints, each of the apps instructed users to photograph a mole with a smartphone camera and input other information about the mole. The apps then purported to calculate the mole's melanoma risk as low, medium, or high. The FTC alleged that the marketers deceptively claimed the apps accurately analyzed melanoma risk and could assess such risk in early stages. The marketers lacked adequate evidence to support such claims, the FTC charged.

The maker of Mole Detective must give up profits of $3,930, and the maker of MelApp must give up $17,963.

[via]

iphoneapphelpsearlydetectionofskincancer-5

mzl.tcxgtcgh.640x960-75